Hassan Azzazy
Hassan M. E. Azzazy, PhD Dr. Azzazy is a tenured full professor of Chemistry (2003-present) at the American University in Cairo (AUC). He served as the Chairman of Chemistry Department and Associate Dean for Graduate Studies & Research at the School of Sciences & Engineering, AUC. He is the founder of the Novel Diagnostics & Therapeutics Research group and the director of the International Medical Technologists training program. Dr. Azzazy was a postdoctoral fellow and assistant professor at University of Maryland School of Medicine, Baltimore, MD (1995-2002). Dr. Azzazy is a graduate of Alexandria University, Egypt and received his PhD from the School of Biomedical Sciences, University of North Texas Health Science Center, Fort Worth, TX. He holds two board certifications in Clinical Chemistry and Molecular Diagnostics from the American Board of Clinical Chemistry, Washington, DC. He is certified as a Specialist in Chemistry by the Board of Certification, the American Society for Clinical Pathology in Chicago, IL. Dr. Azzazy has over 72 scientific publications in international refereed journals, 60 conference presentations, and 25 book chapters. He serves on the editorial boards of Clinical Biochemistry (Elsevier), Clinica Chimica Acta (Elsevier), and Clinical Chemistry Laboratory Medicine (De Gruyter). Dr. Azzazy is the co-founder and CTO of D-Kimia innovative diagnostic solutions and co-founder & CEO of NanoEbers for nanofiber wound dressings. Dr. Azzazy is the recipient of many awards including State Prize in Advanced Technological Sciences (ASRT), Excellence in Research Award (AUC), Global Innovator Award (Texas Christian University), and Arab Innovation & Entrepreneurship Award (ASTF, UAE).